Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | +0.79% |
|
-1.54% | +9.40% |
06-25 | Oppenheimer Initiates Clearside Biomedical at Outperform With $5 Price Target | MT |
05-13 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.40% | 95.66M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Transcript : Clearside Biomedical, Inc. Presents at JP Morgan 37th Annual Healthcare conference, Jan-10-2019 08